European neurotechnology sector prepares for responsible innovation seal

A new voluntary ethical label will help organisations demonstrate responsible practices in the world of neurotechnology, making trust a bigger part of the industry

The European Brain Council (EBC) is preparing to launch the Seal of Responsible Neurotechnology, an independent label designed to recognise organisations that go beyond basic regulatory compliance in developing and using technologies that interact with the brain.

Shaping the seal with the sector

On 28 September 2026, the EBC brought together organisations piloting the Seal and independent experts to review progress and refine the Seal of Responsible Neurotechnology.

Start-ups, research institutions and other organisations from across Europe’s neurotechnology ecosystem took part in the discussions. A key focus was ensuring that the Seal is credible, practical and proportionate for organisations of different sizes and with different roles in the sector.

Feedback from the pilot is now shaping the final version of the framework before it is launched. 

Why responsible neurotechnology matters

Neurotechnology is increasingly moving beyond traditional clinical settings. Applications are being developed for use in homes, workplaces and classrooms, bringing technologies that interact with brain activity into more areas of everyday life.

This raises questions about privacy, ethics, and how to handle highly sensitive neurological data. While existing regulations provide some safeguards, organisations face growing expectations to show they address these issues responsibly.

For businesses and researchers, the ability to show strong ethical governance could therefore become increasingly important when working with investors, customers, healthcare providers and the public.

What the Seal will recognise

The Seal of Responsible Neurotechnology will be a voluntary ethical label awarded independently by the EBC. It builds on the European Charter for the Responsible Development of Neurotechnologies, which draws on recommendations from the OECD and UNESCO.

The Seal of Responsible Neurotechnology was refined through public consultation and endorsed by more than 50 organisations, including scientific societies, patient organisations, research institutions and industry representatives.

The Seal will not replace existing regulatory requirements such as CE marking. Instead, it is intended to recognise organisations whose approach to ethical governance goes beyond minimum compliance.

A potential competitive advantage

For companies operating in an increasingly competitive market, the Seal could create a visible way to demonstrate their commitment to responsible innovation.

It is intended to help organisations build confidence among investors, funders, procurement bodies, clinicians and users, while preparing them for increasing scrutiny around artificial intelligence and mental privacy.

Early adopters could also help set expectations for responsible neurotechnology across Europe as the sector continues to develop.